529 - 540 of 7735 results
Coffee with Chopra: Episode 3
0.5 CME CREDIT

Join Dr. Sanjiv Chopra, MD, in this installment of Coffee with Chopra, as he interviews his guest, Dr. Peng Fan, MD, about advances in rheumatology. In this session, the duo will discuss topics including: ANA testing, the revolution of biologics in rheumatology, stem cell treatment, the microbiome, and joint replacements.


0.25 CME CREDIT

Skilled nursing facilities experienced some of the first clusters of COVID-19 outbreaks in the United States. In this episode, geriatrician Lee Lindquist will discuss how the characteristics of COVID-19 and the policies surrounding testing contributed to the spread of the virus in skilled nursing facilities. She will outline practical policies that skilled nursing facilities can implement to protect their patients and staff, and stop the spread of infection within their facilities. Lastly, she will discuss opportunities for policy changes moving forward to prevent future outbreaks in these vulnerable settings. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/18/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the second episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the risks to healthcare workers associated with COVID-19. They will review current data on systems-based solutions to reduce transmission risk, the importance of personal protective equipment (PPE), and when to discontinue precautions in patients with resolved COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/09/2020, and they are subject to change as new information is published.


1 CME CREDIT

In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.


FAQ for the Pharmacotherapy of Alcohol and Opioid Use Disorders

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.Guest: Petros Levounis, MD, MA

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.


0.25 CME CREDIT

What Happened to My Furosemide? Torsemide for Congestive Heart Failure - Frankly Speaking EP 174

Guest: Jill Terrien PhD, ANP-BCMusic Credit: Richard Onorato

0.25 CME

In this episodes, we will discuss a systematic review and meta-analysis that examines outcomes from the use of furosemide compared to torsemide in patients with congestive heart failure.


0.25 CME CREDIT

This podcast will provide an update on the medical literature and practice guidelines pertaining to exercise. Participants will deepen their understanding of the physical and mental health benefits of exercise and will examine the evidence for a variety of common approaches to exercise (cardiovascular, strength training, high intensity interval training). Barriers to participation in exercise regimens – both for patients and providers – will be explored.


1.5 CME CREDITS

Shedding Light on Shingles: The Power of Prevention

1.50 CME
1.50 AANP | 0.36 Pharmacology

Shingles, or herpes zoster (HZ), is a common secondary infection. More than 95% of immunocompetent individuals aged > 50 years are seropositive for the varicella zoster virus and are at risk of developing shingles. This Virtual Expert Roundtable will address the pathophysiology, clinical presentation, and complications of shingles, in addition to the strategies to prevent it.


0.5 CME CREDIT

In the eleventh episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent publications and issues related to COVID-19 including the retraction of two major trials on hydroxychloroquine from Lancet and NEJM, the results of a trial investigating hydroxychloroquine as post-exposure prophylaxis for COVID-19, and the results of a study investigating transmission and viral shedding of COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/10/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the twelfth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the most recent information on COVID-19 vaccines and testing. This episode will review the mechanisms and clinical trial status of each vaccine currently in development and discuss recent literature comparing different sampling techniques in COVID-19 testing. Lastly, faculty will explore how pre-test probability is important to understanding test accuracy. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/16/2020 and they are subject to change as new information is published.